A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid
- 15 August 2005
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (34) , 12095-12100
- https://doi.org/10.1073/pnas.0406731102
Abstract
Transferrin receptor (TfR) has been shown to be significantly overexpressed in different types of cancers. We discovered TfR as a target for gambogic acid (GA), used in traditional Chinese medicine and a previously undiscovered link between TfR and the rapid activation of apoptosis. The binding site of GA on TfR is independent of the transferrin binding site, and it appears that GA potentially inhibits TfR internalization. Down-regulation of TfR by RNA interference decreases sensitivity to GA-induced apoptosis, further supporting TfR as the primary GA receptor. In summary, GA binding to TfR induces a unique signal leading to rapid apoptosis of tumor cells. These results suggest that GA may provide an additional approach for targeting the TfR and its use in cancer therapy.Keywords
This publication has 31 references indexed in Scilit:
- Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreasEuropean Journal Of Cancer, 2004
- Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cellsProceedings of the National Academy of Sciences, 2004
- Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine RepeatsNeuron, 1999
- Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cellsIn vivoInternational Journal of Cancer, 1999
- Mitochondria and ApoptosisScience, 1998
- Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.1997
- Cytotoxic xanthones from Garcinia hanburyiPhytochemistry, 1996
- The role of the transferrin receptor for the activation of human lymphocytesCellular Immunology, 1991
- COMBINATIONS OF ANTITRANSFERRIN RECEPTOR MONOCLONAL-ANTIBODIES INHIBIT HUMAN TUMOR-CELL GROWTH-INVITRO AND INVIVO - EVIDENCE FOR SYNERGISTIC ANTIPROLIFERATIVE EFFECTS1990
- MULTIDRUG (PLEIOTROPIC) RESISTANCE IN DOXORUBICIN-SELECTED VARIANTS OF THE HUMAN SARCOMA CELL-LINE MES-SA1985